MétaCan
← all works

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

2022· review· en· 725 citations· W4311596863 on OpenAlex· 10.1016/s2213-8587(22)00319-9

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.505
GPT teacher head0.555
Teacher spread
0.050 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
The Lancet Diabetes & Endocrinology
Topic
Diabetes Management and Research
Field
Medicine
Canadian institutions
Jewish General Hospital
Funders
European Medicines AgencyEuropean Association for the Study of DiabetesJapan Diabetes SocietyJavna Agencija za Raziskovalno Dejavnost RSAmerican Association of Clinical EndocrinologistsJuvenile Diabetes Research Foundation InternationalAmerican Diabetes Association
Keywords
MedicineStatement (logic)Continuous glucose monitoringMEDLINEIntensive care medicineConsensus conferenceMedical physicsInternal medicineEpistemologyInsulinLaw
Has abstract in OpenAlex
no